Predictive risk factors of steroid dependent nephrotic syndrome in children

Maher Ahmed Abdel-Hafez * , Nagy Mohamed Abou-El-Hana, Adel Ali Erfan, Mohamed El-Gamasy, Hend Abdel-Nabi

Cited by CrossRef: 7

1- Colucci M, Carsetti R, Rosado M, Cascioli S, Bruschi M, Candiano G, Corpetti G, Giardino L, Serafinelli J, Giannone C, Ghiggeri G, Rastaldi M, Sitia R, Emma F, Vivarelli M. Atypical IgM on T cells predict relapse and steroid dependence in idiopathic nephrotic syndrome. Kidney International. 2019;96(4):971 [Crossref]

2- Zaorska K, Zawierucha P, Świerczewska M, Ostalska-Nowicka D, Zachwieja J, Nowicki M. Prediction of steroid resistance and steroid dependence in nephrotic syndrome children. J Transl Med. 2021;19(1) [Crossref]

3- Ang J, Widjanarko N, Ekaputra A. Rituximab versus tacrolimus as corticosteroid-sparing therapy for children with steroid-dependent nephrotic syndrome: A systematic review and meta-analysis of randomized and nonrandomized controlled trials. 2024;36(3):319 [Crossref]

4- Nyrkova P, Savenkova N. Development of hormone dependence in children with hormone-sensitive nephrotic syndrome at the onset of the disease. Ross vestn perinatol pediatr. 2022;66(6):77 [Crossref]

5- Inoki Y, Nishi K, Osaka K, Kaneda T, Akiyama M, Sato M, Ogura M, Kamei K. Association between the time of initial relapse and subsequent relapses in patients with childhood-onset idiopathic nephrotic syndrome. Pediatr Nephrol. 2024;39(8):2393 [Crossref]

6- Cason R, Chambers E, Tu T, Chryst-Stangl M, Huggins K, Lane B, Ochoa A, Jackson A, Gbadegesin R. Genetic risk variants for childhood nephrotic syndrome and corticosteroid response. Front Pediatr. 2023;11 [Crossref]